U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.

Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.

The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.


VIDEOS ON MONOCLONAL ANTIBODIES
 

Video Icon FEATURED VIDEO

Treating High-Risk COVID-19 Patients with Monoclonal Antibodies
In this video you’ll learn more about monoclonal antibodies, how they can be used to treat your high-risk COVID-19 patients, and how you can find treatment centers near you.


PROVIDER EXPERIENCES

In these short videos, providers from different settings discuss how they have increased patient access to monoclonal antibody treatment.

DR. TERESE HAMMOND TESTIMONIAL – EQUITABLE ACCESS TO MONOCLONAL ANTIBODY TREATMENT

Dr. Terese Hammond, Program Medical Director at Providence Saint John's Health Center, discusses her efforts to ensure equitable access to monoclonal antibody treatment for high-risk COVID-19 patients across Southern California.

DR. NATALIE MCGANN: MONOCLONAL ANTIBODY TREATMENT IN A PRIMARY PRACTICE SETTING

Dr. Natalie McGann of TriValley Primary Care discusses how they overcame obstacles to administer monoclonal antibody treatments to high-risk COVID patients in a primary practice setting.

DR. GARY M. WILTZ, CEO/CLINICAL CHO, TECHE ACTION CLINIC

Dr. Gary M. Wiltz, CEO/Clinical CHO, Teche Action Clinic, speaks about the challenges of treating COVID-19 patients in rural Southeast Louisiana. Together with local church leaders and TV and radio stations, he is trying to spread the word about the benefits of the monoclonal antibody treatment for high-risk COVID-19 patients.

COLIN QUINN SPEAKS TO DR. JEFFREY BANDER

Stand-up comedian Colin Quinn (Saturday Night Live, Tough Crowd) speaks to Dr. Jeffrey Bander from Mount Sinai Hospital about how monoclonal antibodies helped him recover from COVID-19.

AMY HILL TESTIMONIAL VIDEO

Filmmaker Amy Hill describes her experience with COVID-19 and how monoclonal antibody treatment helped speed up her recovery.


FACEBOOK LIVE EVENTS

PAST EVENT: DISCUSSION OF MONOCLONAL ANTIBODIES

The Facebook Live event featuring Dr. Vin Gupta and former FDA Commissioner Dr. Robert Califf is available for viewing at any time.

For more information, healthcare providers can visit the resources page.

PAST EVENT: NIH “A” RATING FOR mAbs

Watch Dr. H. Clifford Lane (NIH) and Dr. Raj Gandhi (Harvard) discuss the updated recommendations on the use of monoclonal antibodies released by the NIH COVID-19 Treatment Guidelines Panel in April 2021. Moderated by Ms. Cicely Waters (HHS/ASPR.)


ADMINISTERING mAbs IN YOUR FACILITY

These videos are offered as resources to help you set up monoclonal antibody (mAb) infusions in your facility, learn more about mAb treatment, and increase awareness about its benefits.*

Speakers: Director of Oncology and Therapeutic Infusion Services Jenny Waltzer, Head Nurse Practitioner Lisa Kimbury, Nurse Marisa Marvin, and Infectious Diseases Clinical Pharmacist Victoria Adams.

MONOCLONAL ANTIBODY TREATMENT: PATIENT FLOW

First in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of optimizing efficiency and patient flow.

MONOCLONAL ANTIBODY TREATMENT: ACCOUNTABILITY AND SAFETY

Second in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of ensuring accountability and safety.

MONOCLONAL ANTIBODY TREATMENT: EDUCATION TRAINING

Third in a series from Mount Sinai Hospital in New York, describing the operations and set up of mAb infusion services. This video addresses the topic of managing education and training.

 

*Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation, or favoring by the United States Government. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government, and shall not be used for advertising or product endorsement purposes.